MedTrace Logo

Clinical Trial Comparing Devices Used for Cardioversion of Atrial Fibrillation

NCT05992623 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 546

Last updated 2025-09-22

Study results available
· View outcomes & findings →

Summary

The goal of this single center, investigator initiated, open label prospective randomized controlled trial is to compare the efficacy of a single 200J RBW shock and a single 360J BTE shock. The secondary objective of the study is to compare the frequency of adverse events after one or two 200J RBW or 360J BTE shocks

Conditions

Interventions

DEVICE

Zoll external defibrillator

Patients with AF will be randomized to receive a full output synchronized 200J shock using a RBW waveform from a Zoll defibrillator

DEVICE

Lifepak external defibrillator

Patients with AF will be randomized to receive a full output synchronized 360J shock using a BTE waveform from a Lifepak defibrillator

Sponsors & Collaborators

  • Inova Health Care Services

    lead OTHER

Principal Investigators

  • Brett Atwater, MD · Inova Health Care Services

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-21
Primary Completion
2024-08-14
Completion
2024-12-11
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05992623 on ClinicalTrials.gov